95
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Fighting Counterfeits in Emerging Markets through the Demand Side: The Role of Product Domain in the Effect of Regulatory Fit on Persuasion

, , &

References

  • Aaker, J. L., and A. Y. Lee. 2006. Understanding regulatory fit. Journal of Marketing Research 43 (1):15–9. doi:10.1509/jmkr.43.1.15.
  • Abuiriban, M., and S. El Deeb. 2016. Drug counterfeiting: The situation in the Gaza Strip. American Journal of Medicine and Medical Sciences 6:186–92.
  • Albayrak, T., R. Herstein, M. Caber, N. Drori, M. Bideci, and R. Berger. 2018. Exploring religious tourist experiences in Jerusalem: The intersection of Abrahamic religions. Tourism Management 69:285–96. doi:10.1016/j.tourman.2018.06.022.
  • Amine, L. S., and P. Magnusson. 2007. Cost-benefit models of stakeholders in the global counterfeiting industry and marketing response strategies. Multinational Business Review 15 (2):63–86. doi:10.1108/1525383X200700008.
  • Appelt, K. C., X. Zou, P. Arora, and T. E. Higgins. 2009. Regulatory fit in negotiation: Effects of ‘prevention-buyer’ and ‘promotion-seller’ fit. Social Cognition 27 (3):365–84. doi:10.1521/soco.2009.27.3.365.
  • Assocham (The Associated Chambers of Commerce & Industry of India). 2015. Indian nutraceuticals, herbals and functional foods industry: Emerging on global map.
  • Avnet, T., and T. E. Higgins. 2003. Locomotion, assessment, and regulatory fit: Value transfer from “how” to “what. Journal of Experimental Social Psychology 39 (5):525–30. doi:10.1016/S0022-1031(03)00027-1.
  • Avnet, T., and T. E. Higgins. 2006. How regulatory fit affects value in consumer choices and opinions. Journal of Marketing Research 43 (1):1–10. doi:10.1509/jmkr.43.1.1.
  • Avnet, T., D. Laufer, and T. E. Higgins. 2013. Are all experiences of fit created equal? Two paths to persuasion. Journal of Consumer Psychology 23 (3):301–16. doi:10.1016/j.jcps.2012.10.011.
  • Bansal, D., S. Malla, K. Gudala, and P. Tiwari. 2013. Anti-counterfeit technologies: A pharmaceutical industry perspective. Scientia Pharmaceutica 81 (1):1–13. doi:10.3797/scipharm.1202-03.
  • Basu, S. 2004. E‐government and developing countries: An overview. International Review of Law, Computers & Technology 18 (1):109–32. doi:10.1080/13600860410001674779.
  • Berger, R., B. Bulmash, N. Drori, O. Ben-Assuli, and R. Herstein. 2020. The patient–physician relationship: An account of the physician’s perspective. Israel Journal of Health Policy Research 9 (1):33–49. doi:10.1186/s13584-020-00375-4.
  • Berger, R., N. Drori, M. Rachamim, and I. Alon. 2022. Towards an emic model of business culture. Competitiveness Review: 36 (6):1161–1178. doi:10.1108/CR-06-2022-0081.
  • Berger, R., R. B. Bradley, and A. Silbiger. 2021. Scale development and validation for measuring business-to-business Wasta relationships. Journal of Business & Industrial Marketing 36 (12):2201–18. doi:10.1108/JBIM-05-2019-0191.
  • Berman, B. 2008. Strategies to detect and reduce counterfeiting activity. Business Horizons 51 (3):191–9. doi:10.1016/j.bushor.2008.01.002.
  • Blackstone, E. A., P. J. Fuhr, Jr, and S. Pociask. 2014. The health and economic effects of counterfeit drugs. American Health & Drug Benefits 7 (4):216–24.
  • Brockner, J., S. Paruchuri, C. L. Idson, and T. E. Higgins. 2002. Regulatory focus and the probability estimates of conjunctive and disjunctive events. Organizational Behavior and Human Decision Processes 87 (1):5–24. doi:10.1006/obhd.2000.2938.
  • Camacho, C. J., E. T. Higgins, and L. Luger. 2003. Moral value transfer from regulatory fit: What feels right is right and what feels wrong is wrong. Journal of Personality and Social Psychology 84 (3):498–510. doi:10.1037/0022-3514.84.3.498.
  • Cesario, J., E. T. Higgins, and A. A. Scholer. 2008. Regulatory fit and persuasion: Basic principles and remaining questions. Social and Personality Psychology Compass 2 (1):444–63. doi:10.1111/j.1751-9004.2007.00055.x.
  • Cesario, J., H. Grant, and E. T. Higgins. 2004. Regulatory fit and persuasion: Transfer from “feeling right”. Journal of Personality and Social Psychology 86 (3):388–404. doi:10.1037/0022-3514.86.3.388.
  • Chaudhry, P. E., and G. M. Walsh. 1996. An assessment of the impact of counterfeiting in international markets: The piracy paradox persists. The Columbia Journal of World Business 31 (3):34–48. doi:10.1016/S0022-5428(96)90039-3.
  • Clark, F. 2015. Rise in online pharmacies sees counterfeit drugs go global. Lancet (London, England) 386 (10001):1327–8. doi:10.1016/S0140-6736(15)00394-3.
  • Coleman, J. T., B. M. Royne, and R. K. Pounders. 2020. Pride, guilt, and self-regulation in cause-related marketing advertisements. Journal of Advertising 49 (1):34–60. doi:10.1080/00913367.2019.1689871.
  • Dahlgren, C. 2011. Countering counterfeits: An investigation of message-frame and message-focus effects on persuasion. Fordham Business Student Research Journal 1 (1):6–17.
  • Davison, M. 2011. Pharmaceutical anti-counterfeiting: Combating the real danger from fake drugs. John Wiley & Sons.
  • Elhoushy, S., and P. Lanzini. 2021. Factors affecting sustainable consumer behavior in the MENA region: A systematic review. Journal of International Consumer Marketing 33 (3):256–79. doi:10.1080/08961530.2020.1781735.
  • EUIPO. 2016. €10.2 billion lost every year across the EU due to fake medicines. Press release September 29. Accessed July 24, 2022. https://euipo.europa.eu/tunnel-web/secure/webdav/guest/document_library/observatory/resources/research-and-studies/ip_infringement/study9/Press_release-pharmaceutical_sector_en.pdf
  • Hamelin, N., S. Nwankwo, and R. El Hadouchi. 2013. Faking brands’: Consumer responses to counterfeiting. Journal of Consumer Behaviour 12 (3):159–70. doi:10.1002/cb.1406.
  • Herstein, R., N. Drori, R. Berger, and R. B. Barnes. 2015. Anti-counterfeiting strategies and their influence on attitudes of different counterfeit consumer types. Psychology & Marketing 32 (8):842–59. doi:10.1002/mar.20822.
  • Higgins, E. T. 1997. Beyond pleasure and pain. The American Psychologist 52 (12):1280–300. doi:10.1037/0003-066X.52.12.1280.
  • Higgins, E. T. 2002. How self‐regulation creates distinct values: The case of promotion and prevention decision making. Journal of Consumer Psychology 12 (3):177–91. doi:10.1207/153276602760335031.
  • Higgins, E. T. 2008. Culture and personality: Variability across universal motives as the missing link. Social and Personality Psychology Compass 2 (2):608–34. doi:10.1111/j.1751-9004.2007.00075.x.
  • Higgins, E. T., A. Pierro, and A. W. Kruglanski. 2008. Re-thinking culture and personality: How self-regulatory universals create cross-cultural differences. In Handbook of motivation and cognition within and across cultures, ed. R. Sorrentino and S. Yamaguchi. New York: Guilford Press.
  • Higgins, E. T., J. R. C. Roney, E. Crowe, and C. Hymes. 1994. Ideal versus ought predilections for approach and avoidance distinct self-regulatory systems. Journal of Personality and Social Psychology 66 (2):276–86. doi:10.1037/0022-3514.66.2.276.
  • Hoecht, A., and P. Trott. 2014. How should firms deal with counterfeiting? International Journal of Emerging Markets 9 (1):98–119. doi:10.1108/IJOEM-02-2011-0014.
  • Hopkins, D. M., T. L. Kontnik, and T. M. Turnage. 2003. Counterfeiting exposed: Protecting your brand and customers. J. Wiley & Sons.
  • Huang, H., and S. J. Wei. 2006. Monetary policies for developing countries: The role of institutional quality. Journal of International Economics 70 (1):239–52. doi:10.1016/j.jinteco.2005.09.001.
  • Interpol. 2015. Coordinated operation strikes at organized crime with seizure of 20 million illicit medicines. Accessed July 24, 2020. https://www.interpol.int/en/News-and-Events/News/2015/INTERPOL-coordinated-operation-strikes-at-organized-crime-with-seizure-of-20-million-illicit-medicines
  • Kim, Y.-J. 2006. The role of regulatory focus in message framing in antismoking advertisements for adolescents. Journal of Advertising 35 (1):143–51. doi:10.2753/JOA0091-3367350109.
  • Koenig, A. M., J. Cesario, C. D. Molden, S. Kosloff, and E. T. Higgins. 2009. Incidental experiences of regulatory fit and the processing of persuasive appeals. Personality & Social Psychology Bulletin 35 (10):1342–55. doi:10.1177/0146167209339076.
  • Kubic, T. T. 2011. Enforcement efforts and partnership with industry: A needed strategy addressing counterfeit drugs. Journal of Commercial Biotechnology 17 (3):254–9. doi:10.1057/jcb.2011.17.
  • Lalwani, A. K., J. L. Shrum, and C.-Y. Chiu. 2009. Motivated response styles: The role of cultural values, regulatory focus, and self-consciousness in socially desirable responding. Journal of Personality and Social Psychology 96 (4):870–82. doi:10.1037/a0014622.
  • Lee, A. Y., and L. J. Aaker. 2004. Bringing the frame into focus: The influence of regulatory fit on processing fluency and persuasion. Journal of Personality and Social Psychology 86 (2):205–18. doi:10.1037/0022-3514.86.2.205.
  • Leisen, B., and A. Nill. 2001. Combating product counterfeiting: An investigation into the likely effectiveness of a demand-oriented approach. In American Marketing Association. Conference Proceedings. Vol. 12, 271. American Marketing Association.
  • Lockwood, P., H. C. Jordan, and Z. Kunda. 2002. Motivation by positive or negative role models: Regulatory focus determines who will best inspire us. Journal of Personality and Social Psychology, 83 (4):854–64. doi:10.1037/0022-3514.83.4.854.
  • Lybecker, K. M. 2007. Rx roulette: Combatting counterfeit pharmaceuticals in developing nations. Managerial and Decision Economics 28 (4–5):509–20. doi:10.1002/mde.1359.
  • Malik, A., D. Merunka, M. S. Akram, B. R. Barnes, and A. Chen. 2020. Self‐concept, individual characteristics, and counterfeit consumption: Evidence from an emerging market. Psychology & Marketing 37 (10):1378–95. doi:10.1002/mar.21386.
  • Minagawa, T., P. Trott, and A. Hoecht. 2007. Counterfeit, imitation, reverse engineering and learning: Reflections from Chinese manufacturing firms. R&D Management 37 (5):455–67. doi:10.1111/j.1467-9310.2007.00488.x.
  • Pham, M. T., and T. Avnet. 2004. Ideals and oughts and the reliance on affect versus substance in persuasion. Journal of Consumer Research 30 (4):503–18. doi:10.1086/380285.
  • Pham, M. T., and T. Avnet. 2009. Contingent reliance on the affect heuristic as a function of regulatory focus. Organizational Behavior and Human Decision Processes 108 (2):267–78. doi:10.1016/j.obhdp.2008.10.001.
  • Przyswa, E. 2013. Counterfeit medicines and criminal organizations. IRCAM.
  • Qato, D. M., S. J. Guadamuz, B. Al-Shehri, R. Al-Sultan, and R. Shahin. 2021. Pharmaceutical sector in Palestine: An introduction. In Handbook of healthcare in the Arab world, 1503–23. Cham: Springer International Publishing.
  • Rahimnia, F., and N. H. Arian. 2021. Luxury consumption and the moderating role of attitude toward counterfeits: The case of an emerging market. Journal of General Management 47 (1):41–55. doi:10.1177/03063070211013335.
  • Scholer, A. A., X. Zou, K. Fujita, J. S. Stroessner, and E. T. Higgins. 2010. When risk seeking becomes a motivational necessity. Journal of Personality and Social Psychology 99 (2):215–31. doi:10.1037/a0019715.
  • Siva, N. 2010. Tackling the booming trade in counterfeit drugs. Lancet (London, England) 376 (9754):1725–6. doi:10.1016/s0140-6736(10)62118-6.
  • Sonmez, M., D. Yang, and G. Fryxell. 2013. Interactive role of consumer discrimination and branding against counterfeiting: A study of multinational managers’ perception of global brands in China. Journal of Business Ethics 115 (1):195–211. doi:10.1007/s10551-012-1394-3.
  • Staake, T., F. Thiesse, and E. Fleisch. 2009. The emergence of counterfeit trade: A literature review. European Journal of Marketing 43 (3–4):320–49. doi:10.1108/03090560910935451.
  • Sweileh, W. M., H. Zyoud, and S. M. Al-Haddad. 2016. Pharmacy practice in Palestine. In Pharmacy practice in developing countries, 253–66. Academic Press.
  • Vidjro, S. W., F. G. Mati, S. A. Amari, and J. Y. Pabst. 2022. The legal and institutional framework of market surveillance and the fight against spurious, falsely labelled, falsified or counterfeit product in West Africa: The case of Togo. International Journal of Drug Regulatory Affairs 10 (4):24–31. doi:10.22270/ijdra.v10i4.555.
  • Weber, E. U., A.-R. Blais, and E. N. Betz. 2002. A domain‐specific risk‐attitude scale: Measuring risk perceptions and risk behaviors. Journal of Behavioral Decision Making 15 (4):263–90. doi:10.1002/bdm.414.
  • World Health Organization (WHO). 2011. Counterfeit medicines. Accessed July 24, 2022. https://www.gphf.org/images/downloads/library/who_factsheet275.pdf
  • World Health Organization (WHO). 2017. Global surveillance and monitoring system for substandard and falsified medical products. Geneva License: CC BY-NC-SA 3.0 IGO.
  • World Trade Organization (WHO). 2018. Substandard and falsified medical products. Accessed July 24, 2022. https://www.who.int/en/news-room/fact-sheets/detail/substandard-and-falsified-medical-products.
  • Yang, D., and E. G. Fryxell. 2009. Brand positioning and anti-counterfeiting effectiveness. Management International Review 49 (6):759–79. doi:10.1007/s11575-009-0019-2.
  • Zou, X., A. A. Scholer, and E. T. Higgins. 2014. In pursuit of progress: Promotion motivation and risk preference in the domain of gains. Journal of Personality and Social Psychology 106 (2):183–201. doi:10.1037/a0035391.
  • Zou, X., and A. A. Scholer. 2016. Motivational affordance and risk-taking across decision domains. Personality & Social Psychology Bulletin 42 (3):275–89. doi:10.1177/0146167215626706.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.